Marijuana
CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That
Agency has the authority to carve out an exception to existing laws.
Tilray Could Be Poised to Move Higher
There has been some recent consolidation and accumulation in the cannabis stock that could be setting the stage for an upside move.
The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It
Let's see how the charts of GWPH are shaping up.
Disciplined Traders Could Go Long Aphria for a Recovery Rally
The charts of the cannabis producer indicate that its shares have found a support level.
Cannabis Firm Aphria Reports Stellar Earnings
I think Aphria is starting to show its potential.
CBD Is Flexing on the Marijuana Industry
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
Cronos Group Could Break Key Moving Averages - Protect Long Positions
Let's look at the chart of CRON.
OrganiGram Could Climb Higher, but You Need Discipline Before Buying
Here's how to play OGI stock right now.
Prohibition and the Paradoxical Proclivity of Cannabis Consumption
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Not High on Canopy Growth's Earnings? Take a Deeper Look
At first glance, CGC's report looks like a drag, but you must dig into the weeds to see how timing and the industry are at play.